Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 13,100 shares, a growth of 5.6% from the March 31st total of 12,400 shares. Based on an average daily volume of 6,600 shares, the days-to-cover ratio is currently 2.0 days.
Arch Therapeutics Price Performance
Shares of ARTH opened at $1.18 on Thursday. The firm’s 50 day simple moving average is $1.74 and its 200 day simple moving average is $3.31. Arch Therapeutics has a 1-year low of $0.39 and a 1-year high of $18.00.
Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) last issued its quarterly earnings results on Tuesday, February 20th. The biotechnology company reported ($0.57) EPS for the quarter. The business had revenue of $0.05 million for the quarter.
About Arch Therapeutics
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Recommended Stories
- Five stocks we like better than Arch Therapeutics
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- AMD is Down 35%. Now is the Time to Buy the Dip
- Conference Calls and Individual Investors
- Amazon Stands Tall: New Highs Are in Sight
- What is MarketRank™? How to Use it
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
